| Literature DB >> 32000219 |
Nicole K Zagelbaum1, Jasjit Bhinder, Chhaya Aggarwal Gupta, William H Frishman, Wilbert S Aronow.
Abstract
Peripartum cardiomyopathy is a rare and a severe form of heart failure that affects women during pregnancy or shortly after delivery. Risk factors include advanced age, race, multiparity, multifetal pregnancy, socioeconomic disparity, and medical comorbidities including systemic hypertension, diabetes, asthma, and anemia. Peripartum cardiomyopathy is associated with increased morbidity and mortality, as well as a detrimental long-term impact on quality of life. Its etiology is not clear, although it is thought to be a combined effect of a hyperdynamic fluid state associated with pregnancy, hormonal changes unique to gestation, and a genetic predisposition. There is no current expert consensus on an optimal treatment regimen. This article will provide a comprehensive review and update on this important disease state.Entities:
Mesh:
Year: 2020 PMID: 32000219 DOI: 10.1097/CRD.0000000000000249
Source DB: PubMed Journal: Cardiol Rev ISSN: 1061-5377 Impact factor: 2.644